Close

Product Liability Lawyer Blog

Updated:

Actos Bladder Cancer Bellwether Trial Begins

A federal jury is preparing to hear a bellwether case regarding the alleged cancer-causing diabetes drug Actos, manufactured by Asia’s largest drugmaker, Takeda Pharmaceuticals. The plaintiff in Terrence Allen et ux. v. Takeda Pharmaceuticals North America Inc. et al alleges damages in excess of $75,000 after he says he developed…

Updated:

Maine’s Relaxed Import Drug Law & Risk of Dangerous Drugs

Concerns regarding defective drugs in New England are heightened, following Maine’s recent passage of a law that allows residents there to import prescription drugs from overseas. The policy’s staunch critics include the Pharmaceutical Research and Manufacturer’s of America, the Maine Pharmacy Association and big-name drug manufacturers such as Pfizer and…

Updated:

Biomet Looks Ahead as Defective Hip Cases Move Forward

Biomet recently announced its financial results for the second quarter, indicating an increase in consolidated net sales and announcing the commercial launch of the company’s G7™ Acetabular System in 2014. The financial release indicated that the report contained forward looking statements and that the company’s actual results could be affected…

Updated:

Leukemia Drug Iclusig Expected to Resume Marketing Amid Safety Concerns

A new leukemia drug hit the market last year – and approval was promptly suspended by the U.S. Food and Drug Administration amid concerns that it caused the potential for life-threatening blood clots and a severe restriction of the blood vessels. The drug, known as Iclusig and ponatinib, has reportedly…

Updated:

Faulty Hip Replacements Result in $56 Million Settlement from Biomet

Biomet Inc., a medical device manufacturer based in the U.S., has agreed to pay a minimum of $56 million in order to settle a multi-district lawsuit stemming from defective metal hip replacements. Court filings in the case of In Re: Biomet M2A Magnum Hip Implant Products Liability Litigation, from the…

Updated:

FDA Requests Reports on Defective Tobacco Products

Officials with the Food and Drug Administration (FDA) recently unveiled a new online tool to let consumers report problems with any tobacco products. The Safety Reporting Portal (SRP) has been updated and now contains a new category for tobacco products. Under the update, health care professionals and consumers are provided…

Updated:

Boston Attorney Jeffrey S. Glassman Joins Transvaginal Mesh MDL

Transvaginal mesh products were marketed to women seeking treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Many women who had these products implanted have experienced serious complications, resulting in significant pain and necessitating revision surgeries. Thousands of women filed lawsuits resulting from the complications, and the cases…

Contact Us